Morgan Stanley cuts Ionis price target to $104 from $110
Morgan Stanley cut its price target on Ionis Pharmaceuticals to $104.00 per share from $110.00, according to Benzinga ratings actions via TradingView News.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.